|
Press Releases |
|
|
|
Tuesday, December 2, 2014 |
|
Cytokinetics Announces Presentations Relating to Tirasemtiv at the 25th International Symposium on ALS/MND |
Cytokinetics (Nasdaq: CYTK) announced today that presentations relating to tirasemtiv are scheduled during the 25th International Symposium on ALS/MND to be held December 5-7, 2014 at the Square Brussels Meeting Centre in Brussels, Belgium. more info >> |
|
Thursday, November 27, 2014 |
|
Cytokinetics to Participate in the 26th Annual Piper Jaffray Healthcare Conference |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a panel presentation during the upcoming 26th Annual Piper Jaffray Healthcare Conference. more info >> |
|
Tuesday, November 11, 2014 |
|
Cytokinetics' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the Company's President and CEO, Robert Blum, received the 2014 Lou Gehrig Iron Horse Award from ALS Therapy Development Institute (ALS.net) at the Fourth Annual A White Coat Affair Gala on Saturday, November 8, 2014. more info >> |
|
Friday, October 31, 2014 |
|
Cytokinetics, Incorporated Reports Third Quarter 2014 Financial Results |
Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues for the third quarter of 2014 were $9.4 million, compared to $4.5 million during the same period in 2013. more info >> |
|
Tuesday, October 28, 2014 |
|
Cytokinetics Provides Development Program Update for Omecamtiv Mecarbil |
Cytokinetics, Incorporated (Nasdaq: CYTK) provided an update today relating to omecamtiv mecarbil, the company's lead drug candidate from its cardiac muscle contractility program. more info >> |
|
Tuesday, October 21, 2014 |
|
Cytokinetics Provides Development Program Update for Tirasemtiv |
Cytokinetics, Incorporated (Nasdaq: CYTK) provided a program update today relating to tirasemtiv, the company's lead drug candidate from its skeletal muscle contractility program. more info >> |
|
Friday, October 17, 2014 |
|
Cytokinetics to Announce Third Quarter Results on October 30, 2014 |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report third quarter results on Thursday, October 30, 2014 at 4:00 PM Eastern Time. more info >> |
|
Tuesday, October 14, 2014 |
|
Cytokinetics Announces Development Program Update for CK-2127107 |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the completion of five Phase I clinical trials evaluating CK-2127107 in healthy volunteers, and certain other Phase II readiness activities, all in connection with the agreed development plan under the collaboration between Cytokinetics and Astellas Pharma Inc. more info >> |
|
Friday, August 8, 2014 |
|
Cytokinetics to Present at the 34th Annual Canaccord Global Growth Conference |
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the 34th Annual Canaccord Global Health Conference on August 14, 2014 at 10:30 AM Eastern time at the Intercontinental Hotel in Boston, MA. more info >> |
|
Thursday, July 31, 2014 |
|
Cytokinetics, Incorporated Reports Second Quarter 2014 Financial Results |
Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues for the second quarter of 2014 were $7.8 million, compared to $1.0 million during the same period in 2013. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Finerca Celebrates Milestone of 10,000 Clients with Launch of Exclusive Master Course in CFD Trading
Mar 29, 2024 06:48: JST
|
|
|
Avance Clinical將在世界疫苗大會上分享最新的疫苗臨床試驗新聞,包括HIV-1研究
Mar 29, 2024 06:33 HKT/SGT
|
|
|
Avance Clinical将在世界疫苗大会上分享最新的疫苗临床试验新闻,包括HIV-1研究
Mar 29, 2024 06:22 HKT/SGT
|
|
|
703-Carat L'Heure Bleu Tanzanite Carving Sets New GUINNESS WORLD RECORDS(TM) Title as World's Largest Cut Tanzanite
Mar 29, 2024 06:00 HKT/SGT
|
|
|
Finerca Celebrates Milestone of 10,000 Clients with Launch of Exclusive Master Course in CFD Trading
Mar 29, 2024 05:36 HKT/SGT
|
|
|
Atlas Lithium Secures US$ 30,000,000 Strategic Investment and Offtake Agreement from Mitsui
Mar 28, 2024 19:09 HKT/SGT
|
|
|
王朝酒业公布2023年全年业绩
Mar 28, 2024 17:45 HKT/SGT
|
|
|
王朝酒業公佈2023年全年業績
Mar 28, 2024 17:42 HKT/SGT
|
|
|
Dynasty Fine Wines Announces 2023 Annual Results
Mar 28, 2024 17:35 HKT/SGT
|
|
|
东软教育:内生高质量发展 数字化赋能打开长远增长空间
Mar 28, 2024 16:45 HKT/SGT
|
|
|
東軟教育:內生高質量發展 數字化賦能打開長遠增長空間
Mar 28, 2024 16:42 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
Mar 28, 2024 16:45 JST
|
|
|
浙江沪杭甬:业绩稳健向好 积极回馈股东 分红总额增长17.7%
Mar 28, 2024 15:43 HKT/SGT
|
|
|
浙江滬杭甬:業績穩健向好 積極回饋股東 分紅總額增長17.7%
Mar 28, 2024 15:37 HKT/SGT
|
|
|
2023年收入、利潤實現「雙增長」 復星下一步:「深挖礦」,穩盈利
Mar 28, 2024 15:31 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|